Business
BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- Jefferies Gene Therapy/Editing Summit on October 28 at 2:30pm ET - Credit Suisse 30th Annual Healthcare Conference on November 10 at 1:50pm ET - Barclays
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"- Jefferies Gene Therapy/Editing Summit on October 28 at 2:30pm ET\n - Credit Suisse 30th Annual Healthcare Conference on November 10 at 1:50pm ET\n - Barclays Gene Editing & Gene Therapy Summit on November 15 at 4:00pm ET\n - Stifel 2021 Virtual Healthcare Conference on November 17 at 11:20am ET\n\n\nSAN RAFAEL, Calif., Oct. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.\n\n \n \n \n \n \n \n\n \nAbout BioMarinBioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release.\nContacts: \nInvestors \nMedia\nTraci McCarty \nDebra Charlesworth\nBioMarin Pharmaceutical Inc. \nBioMarin Pharmaceutical Inc.\n(415) 455-7558 \n(415) 455-7451\n \n \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301407128.html\nSOURCE BioMarin Pharmaceutical Inc.","length":6690,"tagName":"div"}]